The Impact of Interferon Lambda 3 Gene Polymorphism on Natural Course and Treatment of Hepatitis C

The Impact of Interferon Lambda 3 Gene Polymorphism on Natural Course and Treatment of Hepatitis C

Host genetic factors may predict the outcome and treatment response in hepatitis C virus (HCV) infection. Very recently, three landmark genome-wide association studies identified single nucleotide polymorphisms near the interleukin 28B (IL28B) region which were more frequent in responders to treatme...

Full description

Saved in:

Bibliographic Details
Main Authors:	F. Bellanti, G. Vendemiale, E. Altomare, G. Serviddio
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	Clinical and Developmental Immunology
Online Access:	http://dx.doi.org/10.1155/2012/849373
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interferon Lambda: A New Sword in Cancer Immunotherapy
by: Ahmed Lasfar, et al.
Published: (2011-01-01)

Homeostatic antiviral protection of the neonatal gut epithelium by interferon lambda
by: Bryan Ramirez Reyes, et al.
Published: (2025-02-01)

The impact of genetic polymorphisms of IL28B gene on the efficacy of antiviral therapy of the chronic hepatitis C by using the standard Interferon-<i>α</i>
by: A. V. Lapshin, et al.
Published: (2013-03-01)

Pegilated interferon α2а in treatment of chronic hepatitis C
by: P. O. Bogomolov, et al.
Published: (2012-09-01)

Expression of Interferon Effector Gene SART1 Correlates with Interferon Treatment Response against Hepatitis B Infection
by: Yong Li, et al.
Published: (2016-01-01)

Retreatment with Pegylated Interferon Alpha-2a and Ribavirin in Patients with Chronic Hepatitis C Who Have Relapsed or Not Responded to a First Course of Pegylated Interferon-Based Therapy
by: Eric M Yoshida, et al.
Published: (2009-01-01)

Failure of Ketoprofen and Interferon Combination Therapy to Improve Interferon-Resistant Chronic Hepatitis C
by: Frank H Anderson, et al.
Published: (1997-01-01)

Efficacy of pegylated interferon alfa-2b «Algeron» in the treatment of chronic hepatitis C
by: M. V. Mayevskaya, et al.
Published: (2013-03-01)

Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm?
by: S. N. Batskikh
Published: (2014-10-01)

Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
by: R. Rodríguez-Lojo, et al.
Published: (2010-01-01)

Interferon Treatment of Hepatitis C Reinfection after Liver Transplantation: A Meta-Analysis
by: Yaqin Chen, et al.
Published: (2015-01-01)

Association between Interferon-Inducible Protein 6 () Polymorphisms and Hepatitis B Virus Clearance
by: Geun-Hee Park, et al.
Published: (2013-03-01)

Acute Hepatitis Induced by Alpha-Interferon in a Patient with Chronic Hepatitis C
by: Ivan Kraus, et al.
Published: (2001-01-01)

Inflammasome Genes’ Polymorphisms in Egyptian Chronic Hepatitis C Patients: Influence on Vulnerability to Infection and Response to Treatment
by: Shady Z. K. Estfanous, et al.
Published: (2019-01-01)

Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)
by: Marina V. Mayevskaya, et al.
Published: (2018-08-01)

High Dose Consensus Interferon in Nonresponders to Interferon Alpha-2B and Ribavirin with Chronic Hepatitis C
by: David N Moskovitz, et al.
Published: (2003-01-01)

Russian interferon <i>α</i>-2b drug in the treatment of chronic hepatitis C
by: N. B. Kovaleva
Published: (2014-08-01)

Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy
by: Bassem Refaat, et al.
Published: (2015-01-01)

Onset of Celiac Disease after Treatment of Chronic Hepatitis C with Interferon Based Triple Therapy
by: Amandeep Singh, et al.
Published: (2015-01-01)

Explore the properties of $$\Lambda (1670)$$ Λ ( 1670 ) in the Cabibbo-favored process $$\Lambda ^+_c \rightarrow p K^- \pi ^+$$ Λ c + → p K - π +
by: Sheng-Chao Zhang, et al.
Published: (2024-12-01)

The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy
by: Janina Bruening, et al.
Published: (2017-01-01)

Early Prediction of Nonresponders to Treatment with Interferon Alpha-2B and Ribavirin in Patients with Chronic Hepatitis C
by: Louis WC Liu, et al.
Published: (2003-01-01)

Form factors of $$\varLambda _b^0 \rightarrow \varLambda _c(2595)^+$$ Λ b 0 → Λ c ( 2595 ) + within light-cone QCD sum rules
by: Hui-Hui Duan, et al.
Published: (2024-12-01)

Pilot Study of Ofloxacin and Interferon-Alpha Combination Therapy for Chronic Hepatitis C without Sustained Response to Initial Interferon Therapy
by: Masafumi Komatsu, et al.
Published: (1997-01-01)

Polymorphism of renin — angiotensin system genes in progression of liver fibrosis in patients with chronic hepatitis C
by: O. V. Taratina, et al.
Published: (2014-08-01)

Restoration of Innate and Adaptive Immune Responses by HCV Viral Inhibition with an Induction Approach Using Natural Interferon-Beta in Chronic Hepatitis C
by: Y. Kishida, et al.
Published: (2012-01-01)

A Multicentre Randomized Controlled Trial of Recombinant Interferon-Alpha-2a in the Treatment of Patients with Chronic Hepatitis C
by: Masafumi Komatsu, et al.
Published: (1997-01-01)

Ischemic Colitis During Pegylated Interferon-Alpha and Ribavirin Therapy for Chronic Hepatitis C
by: Yvette Leung, et al.
Published: (2006-01-01)

Chronic hepatitis C course at elderly and therapeutic approach
by: M. V. Mayevskaya, et al.
Published: (2011-02-01)

Treatment of Chronic Viral Hepatitis with Alpha-Interferon: A Consensus Conference Report
by: The CASL Hepatitis Consensus Group
Published: (1994-01-01)

Theoretical study of the open-flavored tetraquark $$T_{c\bar{s}}(2900)$$ T c s ¯ ( 2900 ) in the process $$\Lambda _b\rightarrow K^0D^0\Lambda $$ Λ b → K 0 D 0 Λ
by: Wen-Tao Lyu, et al.
Published: (2025-02-01)

Early Changes in Hepatitis C Virus (HCV) RNA Levels Predict Response to Interferon Treatment in Non-Cirrhotic HCV Patients
by: Glen Fallows, et al.
Published: (2000-01-01)

Genetic polymorphism of hepatitis C virus and risk of hepatocellular carcinoma
by: S. N. Mammayev, et al.
Published: (2014-09-01)

NS5A replication complex inhibitor daclatasvir in the basis of chronic hepatitis C interferon-free therapy
by: M. V. Mayevskaya, et al.
Published: (2015-12-01)

Hepatitis C Virus Clearance after Discontinuation of Pegylated Interferon Alpha-2a Monotherapy in a Child
by: Takeshi Endo, et al.
Published: (2012-01-01)

Autoimmune Hepatitis in Brazilian Children: IgE and Genetic Polymorphisms in Associated Genes
by: Léa Campos de Oliveira, et al.
Published: (2015-01-01)

Gene Polymorphisms in Chronic Periodontitis
by: Marja L. Laine, et al.
Published: (2010-01-01)

Hepatitis C diagnostics and treatment guidelines in adults
by: V. T. Ivashkin, et al.
Published: (2013-05-01)

Interleukin IL1a and IL6 gene polymorphism: search for association with APOE genotype and clinical course of sporadic Alzheimer’s disease
by: G. Pšemeneckienė, et al.
Published: (2019-09-01)

Real World Experience of Chronic Hepatitis C Retreatment with Genotype Specific Regimens in Nonresponders to Previous Interferon-Free Therapy
by: Dorota Zarębska-Michaluk, et al.
Published: (2019-01-01)